Cargando…
Pulmonary vasodilator use in continuous-flow left ventricular assist device management
Pulmonary hypertension (PH) due to left heart disease is the most common etiology for PH. PH in patients with heart failure with reduced fraction (HFrEF) is associated with reduced functional capacity and increased mortality. PH-HFrEF can be isolated post-capillary or combined pre- and post-capillar...
Autores principales: | Pirlamarla, Preethi, Rame, Eduardo, Hoopes, Charles, Rajapreyar, Indranee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039680/ https://www.ncbi.nlm.nih.gov/pubmed/33850919 http://dx.doi.org/10.21037/atm-20-4710 |
Ejemplares similares
-
Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Shehab, Sajad, et al.
Publicado: (2019) -
Antiplatelet and anticoagulation strategies for left ventricular assist devices
por: Loyaga-Rendon, Renzo Y., et al.
Publicado: (2021) -
Predictors of right ventricular failure after left ventricular assist device implantation
por: Koprivanac, Marijan, et al.
Publicado: (2014) -
Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure
por: Van Iterson, Erik H
Publicado: (2019) -
Ventricular assist device selection: which one and when?
por: Stulak, John M., et al.
Publicado: (2014)